[국제]’AZ Vaccine, Rare Thrombosis Association Review Results’ Announced as Early as Today

[국제]’AZ Vaccine, Rare Thrombosis Association Review Results’ Announced as Early as Today

by

[앵커]

The results of an evaluation by the European Medicines Agency, which has been investigating the link between the AstraZeneca COVID-19 vaccine and the outbreak of rare blood clots, are released as early as today.

The European Medicines Agency is in the position that the final review has not yet been completed, and it is noted that a senior official at the agency revealed that there appears to be a causal link between the vaccine and the occurrence of rare blood clots.

Reporter Park Kyung-seok reports.

[기자]

Marco Cavaleri, head of vaccine strategy at the European Medicines Agency, says there seems to be a clear link between the AstraZeneca vaccine and some rare thrombosis.

But he added, “We still don’t know what causes this reaction.

In response to Cavalelli’s remarks, who are responsible for evaluating the vaccine, the European Medicines Agency has blocked further controversy, saying it has not yet reached a conclusion as to whether it is relevant.

The European Medicines Agency will issue new recommendations today or tomorrow as soon as the safety committee’s evaluation work is completed.

The World Health Organization (WHO), which has recommended continued vaccination of the AstraZeneca vaccine, has stepped out to soothe anxiety, saying that there is no link between the vaccine and thrombotic disease right now.

British Prime Minister Boris Johnson also stressed the need to continue vaccinating AstraZeneca by visiting a vaccine raw material plant.

[보리스 존슨 / 영국 총리 : 백신을 계속 맞아야 합니다. 성인의 60%가 접종을 마쳤습니다. 코로나19 감염 상황에 긍정적인 효과가 분명히 나타나기 시작했습니다.]

With some European countries restricting or stopping AstraZeneca vaccination, new recommendations from the European Medicines Agency on the involvement of rare blood clots are drawing attention.

This is YTN Park Kyung-seok.

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]

.Source